Search

Search Constraints

You searched for: Author/Creator Comba, Andrea

Search Results

1. Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab. Issue 10 (12th April 2018)

2. PDTM-20. THE HISTONE MUTATION H3.3-G34R ENCOUNTERED IN PEDIATRIC HIGH GRADE GLIOMA MODIFIES THE TUMOR IMMUNE MICROENVIRONMENT RENDERING IT MORE PERMISSIVE FOR IMMUNE MEDIATED THERAPIES. (11th November 2019)

3. TMIC-62. FYN, AN EFFECTOR OF ONCOGENIC RECEPTOR TYROSINE KINASES SIGNALING IN GLIOBLASTOMA, INHIBITS ANTI-GLIOMA IMMUNE RESPONSES: IMPLICATIONS FOR IMMUNOTHERAPY. (11th November 2019)

5. CSIG-08. DYNAMICS OF GLIOMA GROWTH: SELF-ORGANIZATION GUIDES THE PATTERNING OF THE EXTRACELLULAR MATRIX AND REGULATES TUMOR PROGRESSION. (5th November 2018)

6. CSIG-07. COMPARATIVE RNA-SEQ ANALYSIS OF GLIOMAS OF DIFFERENT MALIGNANCY IDENTIFIES FYN AS A NOVEL REGULATOR OF GBM AGGRESSIVENESS. (5th November 2018)

8. ATIM-44. A PHASE I FIRST-IN-HUMAN TRIAL OF TWO ADENOVIRAL VECTORS EXPRESSING HSV1-TK AND FLT3L FOR TREATING NEWLY DIAGNOSED RESECTABLE MALIGNANT GLIOMA: THERAPEUTIC REPROGRAMMING OF THE BRAIN IMMUNE SYSTEM. (11th November 2019)

9. Erratum: Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses. Issue 8 (19th May 2020)